Suchergebnisse - "Mortezaee, Keywan"

PubPharm (24)

1

The impact of hypoxia on tumor-mediated bypassing anti-PD-(L)1 therapy

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von Mortezaee, K. | Majidpoor, J. | Kharazinejad, E.

2

The impact of hypoxia on extracellular vesicle secretome profile of cancer

enthalten in: Medical oncology (Northwood, London, England) | 2023

von Mortezaee, K. | Majidpoor, J.

3

The impact of hypoxia on extracellular vesicle secretome profile of cancer

enthalten in: Medical oncology | 2023

von Mortezaee, K. | Majidpoor, J.

4

The impact of hypoxia on extracellular vesicle secretome profile of cancer

enthalten in: Medical oncology | 2023

von Mortezaee, K. | Majidpoor, J.

5

VISTA immune regulatory effects in bypassing cancer immunotherapy : Updated

enthalten in: Life sciences | 2022

von Mortezaee, K. | Majidpoor, J. | Najafi, S.

6

Epithelial-mesenchymal transition in cancer stemness and heterogeneity : updated

enthalten in: Medical oncology (Northwood, London, England) | 2022

von Mortezaee, K. | Majidpoor, J. | Kharazinejad, E.

7

Epithelial-mesenchymal transition in cancer stemness and heterogeneity: updated

enthalten in: Medical oncology | 2022

von Mortezaee, K. | Majidpoor, J. | Kharazinejad, E.

8

Epithelial-mesenchymal transition in cancer stemness and heterogeneity: updated

enthalten in: Medical oncology | 2022

von Mortezaee, K. | Majidpoor, J. | Kharazinejad, E.

9

Key promoters of tumor hallmarks

enthalten in: International journal of clinical oncology | 2022

von Mortezaee, K. | Majidpoor, J.

10

Interleukin-6 in SARS-CoV-2 induced disease : Interactions and therapeutic applications

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2022

von Majidpoor, J. | Mortezaee, K.